INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

GBIOGeneration Bio Co.

CIK 0001733294

EDGAR filingsOpen in network
Disclosed transactions18
Buys / sells0 / 0
Max Insider Score31
Connections4with evidence

GBIO · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
HY
Howze YalondaINTERIM CEO & PRESIDENT
GBIOGeneration Bio Co.
Option exercise
M—
1,673 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 5, 2026
  • ← Insider ofevidence
    Conway Kevin JohnChief Financial Officer · Jan 16, 2026
  • ← Insider ofevidence
    Howze YalondaCHIEF LEGAL OFFICER · Jan 16, 2026
  • ← Insider ofevidence
    Mcdonough GeoffDirector · Nov 21, 2025
9
HY
Howze YalondaINTERIM CEO & PRESIDENT
GBIOGeneration Bio Co.
Option exercise
M
—
1,673 sh
Feb 2, 2026
Feb 4, 2026
traded Feb 2, 2026
+2d
SEC FORM 4

Evidence

13
HY
Howze YalondaINTERIM CEO & PRESIDENT
GBIOGeneration Bio Co.
Tax withholding
F$2,792
495 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

13
CJ
Conway Kevin JohnChief Financial Officer
GBIOGeneration Bio Co.
Option exercise
M—
235 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

9
CJ
Conway Kevin JohnChief Financial Officer
GBIOGeneration Bio Co.
Tax withholding
F$406
72 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

9
CJ
Conway Kevin JohnChief Financial Officer
GBIOGeneration Bio Co.
Option exercise
M—
235 sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

17
MG
Mcdonough GeoffDirector
GBIOGeneration Bio Co.
Option exercise
M—
395 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

17
HY
Howze YalondaCHIEF LEGAL OFFICER
GBIOGeneration Bio Co.
Option exercise
M—
335 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

9
MG
Mcdonough GeoffDirector
GBIOGeneration Bio Co.
Option exercise
M—
395 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

9
MG
Mcdonough GeoffDirector
GBIOGeneration Bio Co.
Tax withholding
F$773
137 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

9
CJ
Conway Kevin JohnChief Financial Officer
GBIOGeneration Bio Co.
Option exercise
M—
59 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

9
CJ
Conway Kevin JohnChief Financial Officer
GBIOGeneration Bio Co.
Tax withholding
F$95.88
17 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

17
CJ
Conway Kevin JohnChief Financial Officer
GBIOGeneration Bio Co.
Option exercise
M—
59 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

13
HY
Howze YalondaCHIEF LEGAL OFFICER
GBIOGeneration Bio Co.
Option exercise
M—
335 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

9
HY
Howze YalondaCHIEF LEGAL OFFICER
GBIOGeneration Bio Co.
Tax withholding
F$558
99 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC FORM 4

Evidence

31
MG
Mcdonough GeoffDirector
GBIOGeneration Bio Co.
Option exercise
M—
659 sh
Oct 31, 2025Nov 21, 2025
traded Oct 31, 2025
+21dSEC FORM 4

Evidence

19
MG
Mcdonough GeoffDirector
GBIOGeneration Bio Co.
Tax withholding
F$1,614
293 sh
Oct 31, 2025Nov 21, 2025
traded Oct 31, 2025
+21dSEC FORM 4

Evidence

19
MG
Mcdonough GeoffDirector
GBIOGeneration Bio Co.
Option exercise
M—
659 sh
Oct 31, 2025Nov 21, 2025
traded Oct 31, 2025
+21dSEC FORM 4

Evidence

Source error

Price history for GBIO is unavailable.

An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.